Lisata TherapeuticsLSTA

13F holders, Q2 2024 (June 30)
22holders +1
2new positions
1sold out
1famous investor
$3.47avg. 13F price*

At the end of Q2 2024, 22 institutions reported holding Lisata Therapeutics Inc. (LSTA) in their 13F filings, up 1 from Q1 2024. 2 opened new positions and 1 sold out. The largest holders were BML Capital Management, LLC ($988K), Vanguard Group Inc. ($640K) and Renaissance Technologies ($353K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).

Company
Lisata Therapeutics Inc.
CUSIP
128058302
Latest filing quarter
Q2 2026

History

Number of 13F holders

010203040 Q1 2024: 21Q1 2024Q2 2024: 22Q2 2024Q3 2024: 20Q3 2024Q4 2024: 21Q4 2024Q1 2025: 22Q1 2025Q2 2025: 20Q2 2025Q3 2025: 21Q3 2025Q4 2025: 25Q4 2025Q1 2026: 34Q1 2026Q2 2026: 31Q2 2026

Total Exit/New Position Q1 2024 → Q2 2024

InstitutionsTotal Value
New Positions2$8K
Exits1$33K

All 13F filers, Q1 2024 → Q2 2024: 24,794 shares bought and 11,185 shares sold, net +13,609 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 22 holders

BML Capital Management, LLC 0.72% No change 284,669 $988K
Vanguard Group Inc. 0.00% Add +1.4% 184,333 $640K
Renaissance Technologies 0.00% Add +2.1% 101,622 $353K
BlackRock Inc. 0.00% No change 56,013 $194K
Geode Capital Management, LLC 0.00% Add +14.8% 50,898 $177K
Dimensional Fund Advisors LP 0.00% Add +48.2% 17,336 $60K
State Street Corp. 0.00% No change 14,348 $50K
Cook Wealth, LLC 0.02% No change 12,175 $42K
HighTower Advisors, LLC 0.00% No change 10,044 $35K
Bank of America Corp. 0.00% Add +0.6% 9,713 $34K
UBS Group AG 0.00% Add +370800.0% 3,709 $13K
Morgan Stanley 0.00% No change 2,550 $9K
Founders Capital Management 0.00% Add +500.6% 2,000 $7K
Citigroup Inc. 0.00% New 1,436 $5K
Castleview Partners, LLC 0.00% New 1,000 $3K
Tower Research Capital LLC (TRC) 0.00% Reduce -48.4% 440 $2K
JPMorgan Chase & Co. 0.00% No change 16 $56
Steward Partners Investment Advisory, LLC 0.00% No change 6 $21
Barclays PLC 0.00% No change 4 $14
Wells Fargo & Company 0.00% Reduce -98.2% 1 $3
Osaic Holdings, Inc. 0.00% No change 1 $3
Royal Bank of Canada 0.00% No change 52 $0

"% of holder's portfolio" is LSTA's weight in each manager's 13F, not the share of Lisata Therapeutics Inc. the manager owns.